2-113118054-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000259206.9(IL1RN):c.10+26T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 1,608,216 control chromosomes in the GnomAD database, including 56,563 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 4097 hom., cov: 33)
Exomes 𝑓: 0.26 ( 52466 hom. )
Consequence
IL1RN
ENST00000259206.9 intron
ENST00000259206.9 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.703
Genes affected
IL1RN (HGNC:6000): (interleukin 1 receptor antagonist) The protein encoded by this gene is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses, particularly in the acute phase of infection and inflammation. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-113118054-T-C is Benign according to our data. Variant chr2-113118054-T-C is described in ClinVar as [Benign]. Clinvar id is 1244315.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.271 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL1RN | NM_000577.5 | c.10+26T>C | intron_variant | NP_000568.1 | ||||
IL1RN | NM_001318914.2 | c.-273+26T>C | intron_variant | NP_001305843.1 | ||||
IL1RN | NM_173841.3 | c.10+26T>C | intron_variant | NP_776213.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL1RN | ENST00000259206.9 | c.10+26T>C | intron_variant | 1 | ENSP00000259206 | |||||
IL1RN | ENST00000354115.6 | c.10+26T>C | intron_variant | 1 | ENSP00000329072 | A1 | ||||
IL1RN | ENST00000361779.7 | c.-210+26T>C | intron_variant | 1 | ENSP00000354816 |
Frequencies
GnomAD3 genomes AF: 0.209 AC: 31842AN: 152112Hom.: 4091 Cov.: 33
GnomAD3 genomes
AF:
AC:
31842
AN:
152112
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.253 AC: 63648AN: 251392Hom.: 9031 AF XY: 0.256 AC XY: 34797AN XY: 135884
GnomAD3 exomes
AF:
AC:
63648
AN:
251392
Hom.:
AF XY:
AC XY:
34797
AN XY:
135884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.261 AC: 380615AN: 1455984Hom.: 52466 Cov.: 30 AF XY: 0.261 AC XY: 189326AN XY: 724622
GnomAD4 exome
AF:
AC:
380615
AN:
1455984
Hom.:
Cov.:
30
AF XY:
AC XY:
189326
AN XY:
724622
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.209 AC: 31857AN: 152232Hom.: 4097 Cov.: 33 AF XY: 0.212 AC XY: 15801AN XY: 74422
GnomAD4 genome
AF:
AC:
31857
AN:
152232
Hom.:
Cov.:
33
AF XY:
AC XY:
15801
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
679
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 49% of patients studied by a panel of primary immunodeficiencies. Number of patients: 47. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at